Home/Filings/4/0001209191-24-001363
4//SEC Filing

Kenny Kevin J. 4

Accession 0001209191-24-001363

CIK 0000884624other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 4:55 PM ET

Size

9.5 KB

Accession

0001209191-24-001363

Insider Transaction Report

Form 4
Period: 2024-01-08
Kenny Kevin J
President of Global Spine
Transactions
  • Tax Payment

    Common Stock

    2024-01-08$13.29/sh1,511$20,081145,810 total
  • Exercise/Conversion

    Performance Share Units

    2024-01-085,9590 total
    Exercise: $0.00Common Stock (5,959 underlying)
  • Exercise/Conversion

    Common Stock

    2024-01-08+5,959147,321 total
Footnotes (2)
  • [F1]On April 4, 2023, the reporting person was granted 5,959 performance-based restricted stock units (PSUs). Such PSUs vested and converted to common stock on a one-for-one basis on January 8, 2024.
  • [F2]Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The synergy target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).

Issuer

Orthofix Medical Inc.

CIK 0000884624

Entity typeother

Related Parties

1
  • filerCIK 0001520400

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:55 PM ET
Size
9.5 KB